Home Cart Sign in  
Chemical Structure| 47326-86-3 Chemical Structure| 47326-86-3

Structure of WR99210
CAS No.: 47326-86-3

Chemical Structure| 47326-86-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

WR99210 is an orally effective dihydrofolate reductase (DHFR) inhibitor with low toxicity, exhibiting antiparasitic activity against Plasmodium vivax, Plasmodium falciparum (including drug-resistant strains), and Toxoplasma gondii.

Synonyms: BRL 6231 free base

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of WR99210

CAS No. :47326-86-3
Formula : C14H18Cl3N5O2
M.W : 394.68
SMILES Code : NC1=NC(N)=NC(C)(C)N1OCCCOC2=CC(Cl)=C(Cl)C=C2Cl
Synonyms :
BRL 6231 free base
MDL No. :MFCD01679034

Safety of WR99210

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Plasmodium falciparum 3D7 strain 1 nM and 10 nM 24 hours To investigate the impact of WR99210 on the dNTP pool of malaria parasites. Results showed that 10 nM WR99210 significantly reduced dTTP and dGTP levels, while no significant changes were observed at 1 nM concentration. Sci Rep. 2022 Nov 19;12(1):19926
Plasmodium falciparum Dd2attB parasites 10 nM 3 days Evaluate the effect of WR99210 on parasite growth, results showed WR99210 caused dose-dependent growth inhibition mSphere. 2019 Jan 23;4(1):e00710-18
Plasmodium falciparum B1G9 10 nM 3-24 hours To study the effects of WR99210 on malaria parasites transfected with human DHFR gene. Results showed that B1G9 cells behaved normally in the presence of WR99210, indicating adaptive changes in the transcriptome after long-term exposure. PLoS Pathog. 2008 Nov;4(11):e1000214
Plasmodium falciparum Dd2 10 nM 3-24 hours To study the lethal effects of WR99210 on malaria parasites and their transcriptional responses. Results showed minimal changes in the transcriptome despite 50% loss of cell viability within 6 hours. PLoS Pathog. 2008 Nov;4(11):e1000214
Mycobacterium tuberculosis H37Rv 0 to 70 µM 4 to 6 days WR99210 inhibits the growth of both BCG and M. tuberculosis H37Rv in vitro, with MIC ranging from 1.6 to 6 μM. Antimicrob Agents Chemother. 2002 Nov;46(11):3362-9
Mycobacterium bovis BCG 0 to 70 µM 4 to 6 days WR99210 inhibits the growth of both BCG and M. tuberculosis H37Rv in vitro, with MIC ranging from 1.6 to 6 μM. Antimicrob Agents Chemother. 2002 Nov;46(11):3362-9
Plasmodium falciparum PD-728 isolate 0.07 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the PD-728 isolate, showing an IC50 of 0.07 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum PD-701 isolate 0.04 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the PD-701 isolate, showing an IC50 of 0.04 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum PD-234 isolate 0.06 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the PD-234 isolate, showing an IC50 of 0.06 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum GA3 clone 0.02 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the GA3 clone, showing an IC50 of 0.02 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum CH12 isolate 0.05 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the CH12 isolate, showing an IC50 of 0.05 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum K1 isolate 0.12 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the K1 isolate, showing an IC50 of 0.12 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum D6 clone 0.06 ng/ml 48 hours To evaluate the in vitro antimalarial activity of WR99210 against the D6 clone, showing an IC50 of 0.06 ng/ml Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1
Plasmodium falciparum Dd2attB parasites 10 nM 5 days Evaluate the effect of WR99210 on parasite growth, results showed IPP supplementation reversed WR99210 sensitivity mSphere. 2019 Jan 23;4(1):e00710-18
Babesia duncani 5 nM 7 days To evaluate the inhibitory effect of WR99210 on Babesia duncani and to screen genetically modified parasites. The results showed that 5 nM WR99210 could inhibit 80% of the growth of Babesia duncani, and 96.3% of the parasites expressed eGFP after 7 days. Front Cell Infect Microbiol. 2022 Apr 6;12:844498
Plasmodium falciparum (FCB strain) 0.65 nM to 2.6 nM 72 hours To evaluate the antimalarial effect of WR99210 in vitro, results showed 87% inhibition at 0.65 nM and complete inhibition at 2.6 nM. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10931-6
Plasmodium falciparum Dd2 0.62 nM (EC50) 72 hours Evaluate the EC50 of JP WR99210 against Dd2 strain, showing efficacy at nanomolar concentrations Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01385-20
Plasmodium falciparum NF54 0.056 nM 72 hours Evaluate the half-maximal effective concentration (EC50) of JP WR99210 against NF54 strain, showing efficacy at sub-nanomolar concentrations Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01385-20
Human foreskin fibroblasts 50 nM (IC50) 72 hours To evaluate the inhibitory effect of WR99210 on T. gondii tachyzoites, results showed significant inhibition at low nanomolar concentrations. Antimicrob Agents Chemother. 2005 Aug;49(8):3463-7
Yeast strain TH5 100 µM Approximately 24 hours To evaluate the inhibitory effect of WR99210 on various mutant P. vivax DHFR alleles. Results showed that WR99210 was a more potent inhibitor than pyrimethamine or chlorcycloguanil for all P. vivax dhfr alleles except S58R. Notably, alleles most resistant to pyrimethamine (e.g., 117N and 117N/173L) were highly sensitive to WR99210. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13137-41

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Swiss Webster mice Intraperitoneal infection model with T. gondii RH strain Intraperitoneal injection 1.25 mg/kg/day Once daily for 3 days To evaluate the inhibitory effect of WR99210 on T. gondii tachyzoites in mice, results showed significant reduction in parasite numbers. Antimicrob Agents Chemother. 2005 Aug;49(8):3463-7

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.67mL

2.53mL

1.27mL

25.34mL

5.07mL

2.53mL

 

Historical Records

Categories